These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3532417)

  • 1. Stability of prostacyclin in human and rabbit whole blood and plasma.
    Lucas FV; Skrinska VA; Chisolm GM; Hesse BL
    Thromb Res; 1986 Aug; 43(4):379-87. PubMed ID: 3532417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostacyclin stability in thrombotic thrombocytopenic purpura. Japan Working Group on TTP].
    Koyama T; Kakishita E
    Nihon Rinsho; 1993 Jan; 51(1):142-5. PubMed ID: 8433507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of prostacyclin from whole blood.
    Skrinska V; Lucas FV
    Prostaglandins; 1981 Sep; 22(3):365-75. PubMed ID: 7029655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the stability of prostacyclin in human, rabbit and rat plasma.
    El Tahir KE; Williams KI; Betteridge DJ
    Prostaglandins Leukot Med; 1983 Feb; 10(2):109-14. PubMed ID: 6342001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin and thromboxane A2 in thrombotic thrombocytopenic purpura.
    Lee SH; Wainscoat JS; Zeitlin H; Bolton FG; Leaver HA; Seawright A; Preece JM
    Br Med J (Clin Res Ed); 1981 Nov; 283(6303):1351-2. PubMed ID: 6797537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous administration of prostacyclin in rabbits: elimination kinetics and blood pressure response.
    Skrinska VA; Lucas FV; Chisolm GM; Hesse BL
    J Lab Clin Med; 1986 Mar; 107(3):187-93. PubMed ID: 3512745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum prostacyclin binding defects in thrombotic thrombocytopenic purpura.
    Wu KK; Hall ER; Rossi EC; Papp AC
    J Clin Invest; 1985 Jan; 75(1):168-74. PubMed ID: 3880771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated prostacyclin degradation in the thrombotic thrombocytopenic purpura.
    Chen YC; McLeod B; Hall ER; Wu KK
    Lancet; 1981 Aug; 2(8241):267-9. PubMed ID: 6114320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological half-life of prostacyclin and 6-oxo-PGF1 alpha levels in plasma of patients with colonic cancer.
    Polterauer P; Sinzinger H; Peskar BA
    Prostaglandins Leukot Med; 1986 Jun; 22(3):249-58. PubMed ID: 3523543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic disposition of prostacyclin in humans.
    Brash AR; Jackson EK; Saggese CA; Lawson JA; Oates JA; FitzGerald GA
    J Pharmacol Exp Ther; 1983 Jul; 226(1):78-87. PubMed ID: 6345756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute stress in rats produces a rapid and sustained increase in prostacyclin production in aortic tissue: dependence on corticosterone.
    Grimée R; Wülfert E
    Life Sci; 1995; 57(1):69-81. PubMed ID: 7596223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostacyclin degradation in patients with quantitative platelet disorders.
    Chen YC; Liu MC; Wang CH
    Prostaglandins Leukot Essent Fatty Acids; 1988 Apr; 32(1):39-43. PubMed ID: 3290905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced biological half-life of plasma prostacyclin in pre-eclampsia.
    Sinzinger H; Weber G
    Arch Gynecol Obstet; 1988; 243(4):187-90. PubMed ID: 3066295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of vascular prostacyclin (PGI2) production by human serum.
    Ritter JM; Orchard MA; Lewis PJ
    Biochem Pharmacol; 1982 Oct; 31(19):3047-50. PubMed ID: 6756409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very low levels of 6-keto-prostaglandin F1 alpha in human plasma.
    Siess W; Dray F
    J Lab Clin Med; 1982 Mar; 99(3):388-98. PubMed ID: 7035588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma-6-oxo-PGF1-alpha but normal PGI2 half-life in patients with maxillo-facial tumors.
    Porteder H; Matejka M; Kment G; Nell A; Sinzinger H
    Prog Clin Biol Res; 1987; 242():123-9. PubMed ID: 3313409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Accelerated degradation of prostacyclin in diabetic plasma--a further factor in the impairment of hemostatic balance?].
    Sinzinger H; Kaliman J; Fitscha P; Peskar BA
    Wien Klin Wochenschr; 1985 Sep; 97(17):693-7. PubMed ID: 3904220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recirculation of prostacyclin (PGI2) in the dog.
    Dusting GJ; Moncada S; Vane JR
    Br J Pharmacol; 1978 Oct; 64(2):315-20. PubMed ID: 361136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium.
    Wautier JL; Pintigny D; Maclouf J; Wautier MP; Corvazier E; Caen J
    J Lab Clin Med; 1986 Mar; 107(3):210-5. PubMed ID: 3081670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.